| 申请日期 | 2026-03-07 | 申请号 | AU2002313682 |
| 公开（公告）号 | AU2002313682B2 | 公开（公告）日 | 2008-10-30 |
| 公开国别 | AU | 申请人省市代码 | 全国 |
| 申请人 | ISIS PHARMACEUTICALS INC | ||
| 简介 | (57) Abstract : Antisense compounds, compositions and methods are provided for modulating the expression of C-reactive protein. The compositions comprise antisense compounds, particularly antisense oligonucleotides, targeted to nucleic acids encoding C-re- ctive protein. Methods of using these compounds for modulation of C-reactive protein expression and for treatment of diseases associated with expression of C-reactive protein are provided. | ||
|
您还没有登录，请登录后查看下载地址
|
客服热线：
手机版
二维码
